Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia

Biological Psychiatry

Volumn 47, Issue 11, 2000, Pages 944-953

  Young, Keith A ^a   Manaye, Kebreten F ^b   Liang, Chang Lin ^b   Hicks, Paul B ^c   German, Dwight C ^b  

^a Neuropsychiat Res Program 151 N   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Anterior nucleus; Mediodorsal nucleus; Postmortem brain; Schizophrenia; Stereology; Thalamus

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN NERVE CELL; CELL COUNT; CELL DENSITY; CONTROLLED STUDY; HISTOLOGY; HUMAN; LEFT HEMISPHERE; LIMBIC SYSTEM; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; STEREOMETRY; THALAMUS ANTERIOR NUCLEUS; THALAMUS DORSOMEDIAL NUCLEUS; THALAMUS NUCLEUS;

AGED; AGED, 80 AND OVER; ANTERIOR THALAMIC NUCLEI; BRAIN; CASE-CONTROL STUDIES; CELL COUNT; HUMANS; MALE; MEDIODORSAL THALAMIC NUCLEUS; MIDDLE AGED; NERVE NET; NEURONS; SCHIZOPHRENIA; VENTRAL THALAMIC NUCLEI;

EID: 0034213870     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00826-X     Document Type: Article

References (62)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E. Jr, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52:1995;258-266.
2. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney W.E. Jr, Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry. 53:1996;425-436.
3. Andreasen N.C. The evolving concept of schizophrenia From Kraepelin to the present and future . Schizophr Res. 28:1997;105-109.
4. Andreasen N.C. The role of the thalamus in schizophrenia. Can J Psychiatry. 42:1997;27-33.
5. Andreasen N.C., Arndt S., Swayze V., Cizadlo T., Flaum M., O'Leary D., et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science. 266:1994;294-298.
6. Andreasen N.C., Carpenter W.T. Diagnosis and classification of schizophrenia. Schizophr Bull. 19:1993;199-214.
7. Andreasen N.C., Ehrhardt J.C., Swayze V.W., Alliger R.J., Yuh W.T.C., Cohen G., et al. Magnetic resonance imaging of the brain in schizophrenia The pathophysiologic significance of structural abnormalities . Arch Gen Psychiatry. 47:1990;35-44.
8. Arnold S.E., Trojanowski J.Q. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol (Berl). 92:1996;217-231.
9. Benes F.M. Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophr Bull. 19:1993;537-549.
10. Berman K.F., Zec R.F., Weinberger D.R. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry. 43:1986;126-135.
11. Buchanan R.W., Vladar K., Barta P.E., Pearlson G.D. Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry. 155:1998;1049-1055.
12. Buchsbaum M.S., Someya T., Teng C.Y., Abel L., Chin S., Najafi A., et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry. 153:1996;191-199.
13. Burnet P.W., Eastwood S.L., Harrison P.J. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology. 15:1996;442-455.
14. Cannon T.D., Van Erp G.M., Huttunen M., Lonnqvist J., Salonen O., Valanne L., et al. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings and controls. Arch Gen Psychiatry. 55:1998;1084-1091.
15. Casselli R.J., Graff-Radford N.R., Rezai K. Thalamocortical diaschesis Single photon emission tomographic study of cortical blood flow changes after focal thalamic infarction . Neuropsychiatry Neuropsychol Behav Neurol. 4:1991;193-214.
16. Chatterjee A., Yapundich R., Mennemeier M., Mountz J.M., Inampudi C., Pan J.W., et al. Thalamic thought disorder On being "a bit addled." Cortex. 33:1997;419-440.
17. Danos P., Baumann B., Bernstein H.-G., Franz M., Stauch R., Northoff G., et al. Schizophrenia and anteroventral thalamic nucleus Selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons . Psychiatry Res. 82:1998;1-10.
18. Daviss S.R., Lewis D.A. Local circuit neurons of the prefrontal cortex in schizophrenia Selective increase in the density of calbindin-immunoreactive neurons . Psychiatry Res. 59:1995;81-96.
19. Erkwoh R., Sabri O., Steinmeyer E.M., Bull U., Sass H. Psychopathological and SPECT findings in never-treated schizophrenia. Acta Psychiatr Scand. 96:1997;51-57.
20. Flaum M.A., Swayze V.W., O'Leary D.S., Yuh W.T.C., Ehrhardt J.C., Arndt S.V., et al. Effects of diagnosis, laterality and gender on brain morphology in schizophrenia. Am J Psychiatry. 152:1995;704-714.
21. Fletcher P.C., McKenna P.J., Friston K.J., Dolan R.J. Brain activations in schizophrenia during a graded memory task studied with functional imaging. Arch Gen Psychiatry. 55:1998;1001-1008.
22. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 65:1998;446-453.
23. Giguere M., Goldman-Rakic P.S. Mediodorsal nucleus Arial, laminar, and tangential distribution of afferents and efferents in the frontal lobe of Rhesus monkeys . J Comp Neurol. 277:1988;195-213.
24. Glantz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of schizophrenic subjects Regional and diagnostic specificity . Arch Gen Psychiatry. 54:1997;660-669.
25. Goldberg T.E., Torrey E.F., Berman K.F., Weinberger D.R. Relations between neuropsychological performance and brain morphological and physiological measures in monozygotic twins discordant for schizophrenia. Psychiatry Res. 55:1994;51-61.
26. Goldstein J.M., Goodman J.M., Seidman L.J., Kennedy D.N., Makris N., Lee H., et al. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry. 56:1999;537-547.
27. Gunderson H.J.G., Jensen E.B. The efficiency of sampling in stereology and its prediction. J Microsc. 147:1987;229-263.
28. Gur R.E., Maany V., Mozley P.D., Swanson C., Bilker W., Gur R.C. Subcortical MRI volumes in neuroleptic naive and treated patients with schizophrenia. Am J Psychiatry. 155:1998;1711-1717.
29. Harding A.J., Halliday G.M., Cullen K. Practical considerations for the use of the optical disector in estimating neuronal number. J Neurosci Methods. 51:1994;83-89.
30. Haznadar M.M., Buchsbaum M.S., Lu C., Hazlett E.A., Seigel B.V., Lohr J., et al. Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry. 154:1997;682-684.
31. Heckers S. Neuropathology of schizophrenia Cortex, thalamus, basal ganglia and neurotransmitter-specific projection systems . Schizophr Bull. 23:1997;401-421.
32. Hunt P.R., Aggleton J.P. Neurotoxic lesions of the dorsomedial thalamus impair the acquisition but not the performance of delayed matching to place by rats; a deficit in the shifting response rules. J Neurosci. 181:1998;9099-9111.
33. Hyde T.M., Weinberger D.R. The brain in schizophrenia. Semin Neurol. 10:1990;276-286.
34. Jones E.G. Cortical development and thalamic pathology in schizophrenia. Schizophr Bull. 23:1997;483-501.
35. Jones E.G. A description of the human thalamus. Steriade M., Jones E.G., McCormick D.A. Thalamus. 1997;425-499 Elsevier, New York. Vol II.
36. Lahti R.A., Roberts R.C., Cochrane E.V., Primus R.J., Gallager D.W., Conley R.R., et al. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue A [3H]NGD-94-1 study . Mol Psychiatry. 6:1998;528-533.
37. McCarley R.W., Wible C.G., Frumin M., Hirayasu Y., Levitt J.L., Fischer I.A., et al. MRI anatomy of schizophrenia. Biol Psychiatry. 45:1999;1099-1119.
38. Mufson E.J., Mesulam M.M. Thalamic connections of the insula in the rhesus monkey and comments on the paralimbic connectivity of the medial pulvinar nucleus. J Comp Neurol. 227:1984;109-120.
39. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry. 47:1990;1023-1028.
40. Pakkenberg B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr Res. 7:1992;95-100.
41. Portas C.M., Goldstein J.M., Shenton M.E., Hokama H.H., Wible C.G., Fischer I., et al. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry. 43:1998;649-659.
42. Raedler T.J., Knable M.B., Weinberger D.R. Schizophrenia as a developmental disorder. Curr Opin Neurobiol. 8:1998;157-161.
43. Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex A postmortem morphometric study of schizophrenia and Huntington's disease . Arch Gen Psychiatry. 55:1998;215-224.
44. Ray J.P., Price J.L. The organization of projections from the mediodorsal nucleus of the thalamus to orbital and medial prefrontal cortex in macaque monkeys. J Comp Neurol. 337:1993;1-31.
45. Sabri O., Erkwoh R., Scheckenberger M., Owega A., Sass H., Buell U. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-medicated schizophrenics. Lancet. 349:1997;1735-1739.
46. Scheaffer R.L., Mendenhall W., Ott L. Elementary Survey Sampling. 5th ed. 1996;PWS-Kent, Boston.
47. Scheibel A.B. The thalamus and neuropsychiatric illness. J Neuropsychiatry. 9:1997;342-353.
48. Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis A circuit based model of schizophrenia . Biol Psychiatry. 45:1999;17-25.
49. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients Application of a three-dimensional, stereologic counting method . J Comp Neurol. 392:1998;402-412.
50. Silbersweig D.A., Stern E., Frith C., Cahill C., Holmes A., Grootoonk S., et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature. 378:1995;176-179.
51. Squire L.R., Moore R.Y. Dorsal thalamic lesion in a noted case of human memory dysfunction. Ann Neurol. 6:1979;503-506.
52. Staal W.G., Hulshoff H.E., Schnack H., Van der Schot A.C., Kahn R.S. Partial volume decrease of the thalamus in relatives of patients with schizophrenia. Am J Psychiatry. 155:1998;1784-1786.
53. Stefen M.D., Murray R.M. Schizophrenia Developmental disturbance of brain and mind . Acta Paediatr. 442:1997;112-116.
54. Stevens A.A., Goldman-Rakic P.S., Gore J.C., Fulbright R.E., Wexler B.E. Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional resonance imaging. Arch Gen Psychiatry. 55:1998;1097-1103.
55. Szelies B., Herholz K., Pawlik G., Karbe H., Hebold I., Wolf-Dieter H. Widespread functional effects of discrete thalamic infarction. Arch Neurol. 48:1991;178-182.
56. van Eden C.G., Rinkins A., Uylings H.M.B. Retrograde degeneration of thalamic neurons in the mediodorsal nucleus after neonatal and adult aspiration lesions of the medial prefrontal cortex in the rat. Implications for mechanisms of functional recovery. Eur J Neurosci. 10:1998;1581-1589.
57. Vogt B.A., Pandya D.N., Sosene D.L. Cingulate cortex of the rhesus monkey I. Cytoarchitecture and thalamic afferents . J Comp Neurol. 262:1987;256-270.
58. Weinberger D.R., Gallhofer B. Cognitive function in schizophrenia. Int Clin Psychopharmacol. 12:(suppl 4):1997;S29-S36.
59. West M.J. New stereological methods for counting neurons. Neurobiol Aging. 14:1994;275-285.
60. Wolkin A., Rusinek H., Vaid G., Arena L., Lafargue T., Sanfilipo M., et al. Structural magnetic image averaging in schizophrenia. Am J Psychiatry. 155:1998;1064-1073.
61. Xuereb J.H., Perry R.H., Candy J.M., Perry E.K., Marshall E., Bonham J.R. Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. Brain. 114:1991;1363-1379.
62. Young K.A., Hicks P.B., Randall P.K., Wilcox R.E. Behavioral and frontal cortical metabolic effects of apomorphine and muscimol microinjections into the mediodorsal thalamic nucleus. J Neural Transm Gen Sect. 98:1994;119-132.